GBA1 and Parkinson disease: Studies using animal models and in vitro pluripotent stem cell technology modeling PD disease have demonstrated increased and more widespread alpha-synuclein distribution and aggregation in the setting of loss of function in the glucocerebrosidase enzyme [22–25].